Bard Associates Inc. reduced its stake in Stericycle, Inc. (NASDAQ:SRCL) by 0.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 33,310 shares of the business services provider’s stock after selling 220 shares during the period. Stericycle accounts for 1.3% of Bard Associates Inc.’s holdings, making the stock its 20th largest position. Bard Associates Inc.’s holdings in Stericycle were worth $2,761,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Eads & Heald Investment Counsel raised its position in Stericycle by 24.9% in the first quarter. Eads & Heald Investment Counsel now owns 4,198 shares of the business services provider’s stock valued at $348,000 after buying an additional 836 shares during the period. Quadrature Capital Ltd bought a new position in Stericycle during the fourth quarter valued at approximately $6,297,000. Silver Heights Capital Management Inc. raised its position in Stericycle by 2.4% in the first quarter. Silver Heights Capital Management Inc. now owns 277,515 shares of the business services provider’s stock valued at $23,003,000 after buying an additional 6,490 shares during the period. Federated Investors Inc. PA raised its position in Stericycle by 31.1% in the fourth quarter. Federated Investors Inc. PA now owns 2,259 shares of the business services provider’s stock valued at $174,000 after buying an additional 536 shares during the period. Finally, Smith Graham & Co. Investment Advisors LP raised its position in Stericycle by 25.2% in the first quarter. Smith Graham & Co. Investment Advisors LP now owns 49,030 shares of the business services provider’s stock valued at $4,064,000 after buying an additional 9,870 shares during the period. 95.50% of the stock is currently owned by institutional investors and hedge funds.
Shares of Stericycle, Inc. (NASDAQ SRCL) traded up 0.54% during trading on Tuesday, hitting $75.89. 569,250 shares of the stock were exchanged. The firm has a market capitalization of $6.47 billion, a P/E ratio of 39.55 and a beta of 0.14. Stericycle, Inc. has a 52 week low of $71.52 and a 52 week high of $107.74. The firm has a 50 day moving average price of $78.00 and a 200 day moving average price of $80.82.
Stericycle (NASDAQ:SRCL) last issued its quarterly earnings results on Thursday, May 4th. The business services provider reported $1.09 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.05 by $0.04. Stericycle had a net margin of 5.23% and a return on equity of 14.40%. The firm had revenue of $892.40 million for the quarter, compared to the consensus estimate of $874.34 million. During the same quarter in the previous year, the company earned $1.11 EPS. The company’s revenue for the quarter was up 2.1% on a year-over-year basis. Analysts forecast that Stericycle, Inc. will post $4.62 EPS for the current fiscal year.
Several research analysts have commented on the company. Jefferies Group LLC set a $108.00 price objective on Stericycle and gave the company a “buy” rating in a research report on Saturday, May 6th. Zacks Investment Research upgraded Stericycle from a “hold” rating to a “buy” rating and set a $97.00 target price for the company in a research note on Tuesday, April 25th. Robert W. Baird cut Stericycle from a “neutral” rating to an “underperform” rating and cut their price target for the company from $74.00 to $73.00 in a report on Friday, May 5th. Deutsche Bank AG cut their price target on Stericycle from $14.00 to $10.00 and set a “buy” rating on the stock in a report on Monday, May 15th. Finally, Barclays PLC assumed coverage on shares of Stericycle in a report on Thursday, April 13th. They set an “overweight” rating and a $100.00 price target on the stock. Three equities research analysts have rated the stock with a sell rating, six have given a hold rating and seven have assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $81.15.
Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with our FREE daily email newsletter.